These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 14903605)

  • 21. COMPARATIVE EFFECTIVENESS OF ORGANIC NITRATES: AN OBJECTIVE STUDY IN MAN.
    WENDKOS MH
    Curr Ther Res Clin Exp; 1963 Sep; 5():484-90. PubMed ID: 14061831
    [No Abstract]   [Full Text] [Related]  

  • 22. Pentaerythritol tetranitrate and metabolites in rat plasma.
    Crew M; Melgar MD; Di Carlo FJ
    J Pharmacol Exp Ther; 1975 Jan; 192(1):218-223. PubMed ID: 1123725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spectrophotometric determination of pentaerythritol tetranitrate in tablets.
    Shingbal DM; Agni RM
    J Assoc Off Anal Chem; 1984; 67(6):1123-4. PubMed ID: 6520087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ABSORPTION, DISTRIBUTION AND EXCRETION OF PENTAERYTHRITOL AND PENTAERYTHRITOL TETRANITRATE BY MICE.
    DICARLO FJ; HARTIGAN JM; COUTINHO CB; PHILLIPS GE
    Proc Soc Exp Biol Med; 1965 Feb; 118():311-5. PubMed ID: 14268608
    [No Abstract]   [Full Text] [Related]  

  • 25. [How is antianginal therapy with pentaerythritol tetranitrate executed?].
    Schneider CA
    Dtsch Med Wochenschr; 2002 Nov; 127(46):2465. PubMed ID: 12432490
    [No Abstract]   [Full Text] [Related]  

  • 26. Study of a timed-release preparation of pentaerythritol tetranitrate.
    Siegel MB
    West Med Med J West; 1966 Aug; 7(8):218-21. PubMed ID: 5341140
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of oral pentaerythritol tetranitrate in cardiac failure and angina pectoris. Assessment by hemodynamic measurement and exercise capacity.
    Amsterdam EA; Lee G; Awan NA; Low R; Mason DT
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2443-6. PubMed ID: 7422533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of continued pentaerythritol tetranitrate administration on myocardial circulation and metabolism.
    BENDER AD; SULLIVAN FJ; HORVATH SM
    Experientia; 1963 May; 19():254-6. PubMed ID: 13967330
    [No Abstract]   [Full Text] [Related]  

  • 29. [Letter: Loss of efficacy in long-term nitrites?].
    Bleifeld W
    Dtsch Med Wochenschr; 1973 Oct; 98(40):1885. PubMed ID: 4762052
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapeutic effects of pentaerythritol tetranitrate in the immediate postmyocardial-infarction period.
    Mellen HS; Goldberg HS; Friedman HF
    N Engl J Med; 1967 Feb; 276(6):319-22. PubMed ID: 6016292
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical study of a prolonged-action coronary vasodilator agent: pentaerythritol tetranitrate].
    Warembourg H; Théry C
    Lille Med; 1966; 11(6):742-5. PubMed ID: 5942195
    [No Abstract]   [Full Text] [Related]  

  • 32. A study of the plasma levels of pentaerythritol mononitrate following administration of pentaerythritol tetranitrate in combination with meprobamate and diphenhydramine.
    Gilbert JD; Aylott RI; Draffan GH; Sögtrop HH
    Arzneimittelforschung; 1982; 32(5):571-4. PubMed ID: 7201836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CONTINUOUS ELECTROCARDIOGRAPHIC RECORDING DURING EXERCISE: ITS USE IN EVALUATING THE EFFECT OF PENTAERYTHRITOL TETRANITRATE.
    KRASNO LR; KIDERA GJ
    Angiology; 1963 Aug; 14():417-25. PubMed ID: 14059280
    [No Abstract]   [Full Text] [Related]  

  • 34. ENZYMATIC DEGRADATION OF PENTAERYTHRITOL TETRANITRATE BY HUMAN BLOOD.
    DICARLO FJ; HARTIGAN JM; PHILLIPS GE
    Proc Soc Exp Biol Med; 1965 Feb; 118():514-6. PubMed ID: 14268670
    [No Abstract]   [Full Text] [Related]  

  • 35. Timed-release pentaerythritol tetranitrate and placebo in the management of angina pectoris.
    Cole RE; Goldberg RI
    Curr Ther Res Clin Exp; 1967 Nov; 9(11):551-7. PubMed ID: 4965503
    [No Abstract]   [Full Text] [Related]  

  • 36. [Anti-anginal activity of a beta-adrenergic blocking agent, butydrine, alone and in association with pentaerythritol tetranitrate, in the aged].
    Gatti A; Scotti G
    Clin Ter; 1967 May; 41(4):363-74. PubMed ID: 5614306
    [No Abstract]   [Full Text] [Related]  

  • 37. Modified NF method for quantitative determination of pentaerythritol tetranitrate.
    Gupta VD
    J Pharm Sci; 1978 May; 67(5):717-8. PubMed ID: 641820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dipole moments and the molecular structure of pentaerythritol tetranitrate.
    SPRINGALL HD; SPEDDING H
    Research; 1949 Jun; 2(6):295. PubMed ID: 18131532
    [No Abstract]   [Full Text] [Related]  

  • 39. The crystal structure of pentaerythritol tetranitrate.
    BOOTH AD; LLEWELLYN FJ
    J Chem Soc; 1947 Jun; ():837-46. PubMed ID: 20259127
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pentaerythritol tetranitrate].
    Friedrich EB; Böhm M
    Dtsch Med Wochenschr; 2006 Apr; 131(14):749-50. PubMed ID: 16596492
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.